Lupin gets USFDA nod to market generic version of CiproLupin said it has received US health regulator USFDA'S approval to market a generic version of Bayer's Cipro, used to treat infections, in ...
06 Mar, 2014, 06.46 PM IST
- Venus Remedies signs deal with Korean co for antibiotic drug
The deal was signed after Companies and Intellectual Property Registration Office (CIPRO) of Republic of South Korea granted the patent to ...
02 May, 2013, 02.51 PM IST
- Consumer staples no more defensive: CLSA
CLSA prefers pharmas to consumer staples as a defensive bet, and replaced Tata Motors with Lupin in its top 5 picks.
04 Jul, 2012, 03.06 PM IST
- Venus gets patent for 'Vancoplus' in South Africa, New Zealand
Drug firm Venus Remedies today said it has received patents in South Africa and New Zealand for its product -- Vancoplus, used in treatment...
29 Nov, 2010, 08.10 PM IST
- US FDA blocks imports from Ranbaxy for poor quality
FDA move does not end US sales by Ranbaxy. The factories with defects are in Dewas and Paonta Sahib. The Top 10 food myths revealed | Bewar...
17 Sep, 2008, 06.33 AM IST
- Aurobindo gets US nod for Ciprofloxin tablets
Aurobindo Pharmaceuticals on Tuesday said it has got USFDA approval for its Ciprofloxacin tablets in 250mg, 500mg and 750mg strengths inste...
05 Jun, 2007, 09.50 PM IST
- Ranbaxy considers acquisitions in US
Ranbaxy Laboratories Ltd, India's biggest drugmaker, considers acquisitions aimed at expanding operations in the US, south and central Amer...
02 May, 2007, 09.55 PM IST
- French co buys IP rights from Lupin
The Mumbai-based pharma co will receive 20 mn euros from Servier Laboratories for its process patents.
18 Apr, 2007, 02.30 AM IST